PRP – Platelet-Rich Plasma or Ovarian Rejuvenation

​

Ovarian and Endometrium Rejuvenation may be used for Patients with Low Ovarian Reserve or Recurrent Implantation Failure.​

​

One of the most intriguing developments in fertility therapy in recent years is the use of PRP, which is still a relatively new procedure. That said, it may be able to address some of the most typical obstacles to a healthy pregnancy.

​

Ovarian rejuvenation or Platelet Rich Plasma (PRP) treatment is a procedure that utilizes the patient’s own blood to isolate the platelet-rich plasma (PRP) which contains stem cells and other growth factors.

​

In recent years, Platelet-Rich Plasma (PRP) has been used in conjunction with traditional fertility treatments like In Vitro Fertilization (IVF) to increase the quality of eggs, the thickness of the uterine lining, and the receptivity of the endometrium, mainly in the treatment of persistent implantation failure experienced over several IVF cycles. Although the treatment still needs additional scientific literature to demonstrate and thoroughly support its general efficacy, it is becoming more and more popular due to its positive clinical outcomes.

​

PRP is used in several reproductive procedures, such as IUI and IVF, to help with and improve egg quantity and quality as well as to increase the thickness of the uterine lining and increase endometrial receptivity during embryo transfer.

​

It is most frequently utilized in patients with a history of recurrent implantation failure (RIF), a condition when numerous IVF transfers fail to result in pregnancy even if high-quality embryos were used each time. Prior to employing donor egg IVF, PRP is often tested; however, it may also be used in conjunction with donor egg cycles and other supportive therapies concentrating on reproductive immunology.

​